🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of toll-like ...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2016-11-07
Trial ID
NCT02927964
Treatments Being Tested
This phase I/II trial studies the side effects of panobinostat nanoparticle...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-05-22
Trial ID
NCT03566199
Treatments Being Tested
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
This phase II trial compares the effect of adding radiation therapy to the ...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2023-10-18
Trial ID
NCT06350162
Treatments Being Tested
Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-01-06
Trial ID
NCT05126849
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of linsitinib ...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2011-12
Trial ID
NCT01465815
This phase II trial studies how well chemotherapy before surgery and radiat...
Status
Active Not Recruiting
Location
University of Arizona Cancer Center-Orange Grove Campus
Start Date
2019-03-12
Trial ID
NCT03493425
This phase I trial tests the safety, side effects, and best dose of ZEN0036...
Status
Recruiting
Location
Keck Medicine of USC Koreatown
Start Date
2023-08-10
Trial ID
NCT05372640
This phase II trial studies how well radiation therapy with or without cisp...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-11-23
Trial ID
NCT02734537
Treatments Being Tested